Inflammatory and autoimmune predictive markers of response to anti‑PD‑1/PD‑L1 therapy in NSCLC and melanoma

Immune checkpoint inhibitors (ICI) are a standard in cancer therapy, but few patients respond to the treatment. The aim of the present study was the determination of immunological markers for monitoring response to ICI. The present study included 74 patients receiving ICI in subsequent [group 1; non...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Experimental and therapeutic medicine 2022-09, Vol.24 (3), Article 557
Hauptverfasser:	Musaelyan, Aram A, Lapin, Sergey V, Urtenova, Margarita A, Odintsova, Svetlana V, Chistyakov, Ivan V, Ulitin, Andrey M, Akopov, Andrey L, Orlov, Sergey V
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Biological markers Biomarkers Cancer Cancer therapies Care and treatment Chemotherapy Cloning Cytokines Disease Dosage and administration Drug therapy Health aspects Immune response Immunology Immunotherapy Lung cancer Lung cancer, Non-small cell Melanoma Metastasis Methods Monoclonal antibodies Patients Physiological aspects Receptor antibodies Test systems Thyroid gland Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!